NDC 73540-003 Yakkongmo Treatment

Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin

NDC Product Information

Yakkongmo Treatment with NDC 73540-003 is a a human over the counter drug product labeled by Bobsnu Co., Ltd.. The generic name of Yakkongmo Treatment is pyrithione zinc, dexpanthenol, niacinamide, biotin. The product's dosage form is liquid and is administered via topical form.

Labeler Name: Bobsnu Co., Ltd.

Dosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Yakkongmo Treatment Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • SALICYLIC ACID .2 g/100mL
  • PYRITHIONE ZINC .6 g/100mL
  • DEXPANTHENOL .5 g/100mL

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • WATER (UNII: 059QF0KO0R)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Bobsnu Co., Ltd.
Labeler Code: 73540
Marketing Category: UNAPPROVED DRUG OTHER - What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 02-22-2020 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Yakkongmo Treatment Product Label Images

Yakkongmo Treatment Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Active Ingredient

Zinc pyrithione, dexpanthenol, salicylic acid

Inactive Ingredient

Water, Dipropylene Glycol, Propylene Glycol, Glycerin, Cetyl Alcohol, Stearyl Alcohol, Glyceryl Stearate, Stearamidopropyl Dimethylamine, Behentrimonium Chloride, CetylEthylhexanoate, PPG-3 Caprylyl Ether, Steartrimonium Chloride, Panthenol, Citrus Limon (Lemon) Peel Oil, AnibaRosodora (Rosewood) Wood Oil, Caprylyl Glycol, Zinc Pyrithione, Salicylic Acid, Hydroxyethylcellulose, Citrus Reticulata (Tangerine) Peel Oil, Niacinamide, Butylene Glycol, Sodium Polynaphthalenesulfonate, 1,2-Hexanediol, Glycine, Glycine Max (Soybean) Seed Extract, VignaRadiata Seed Extract, ArchisHypogaea (Peanut) Fruit Extract, PisumSativum (Pea) Seed Extract, CanavaliaGladiata Extract, PhaseolusAngularis Seed Extract, SesamumIndicum (Sesame) Seed Extract, VacciniumAngustifolium (Blueberry) Fruit Extract, Salvia Hispanica Seed Extract, Nigella Sativa Seed Extract, RubusFruticosus (Blackberry) Fruit Extract, RibesNigrum (Black Currant) Fruit Extract, Oryza Sativa (Rice) Extract, Serine, Glutamic Acid, Aspartic Acid, Leucine, Alanine, Lysine, Arginine, Tyrosine, Phenylalanine, Valine, Threonine, Proline, Isoleucine, OenotheraBiennis (Evening Primrose) Flower Extract, UlmusDavidiana Root Extract, PinusPalustris Leaf Extract, PuerariaLobata Root Extract, Histidine, Methionine, Cysteine, Ethylhexylglycerin, Hydrolyzed Corn Protein, Hydrolyzed Wheat Protein, Hydrolyzed Soy Protein, Acacia Senegal Gum, Sodium Polynaphthalenesulfonate, Peat water, Citric Acid, Hydroxypropyl Methylcellulose, Potassium Sorbate

Otc - Purpose

Helps alleviate symptoms of hair loss


1. If skin develops abnormal symptoms or side effects such as red spots, swelling, and itching while or after using the product, or if the application area develops the symptoms above after exposure to direct sunlight, consult your dermatologist. 2. Do not apply on areas with open wounds. 3. Storage & Handling (1). Keep out of reach of children. (2) Keep away from direct sunlight. 4. If the product gets into eyes, rinse immediately with water 5. If you do not rinse thoroughly with water after use, it may cause hair loss or discoloration.

Otc - Keep Out Of Reach Of Children

Keep Out of Reach of Children


Use once a day as follows: 1) Fully wet hair and scalp with lukewarm water. 2) Dispense an appropriate amount in your palm and evenly apply on hair and scalp. 3) After 2-3 minutes, rinse with lukewarm water.

Indications & Usage

Helps alleviate symptoms of hair loss

* Please review the disclaimer below.